Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats

被引:4
作者
Tatsuta M. [1 ]
Iishi H. [1 ]
Baba M. [1 ]
Yano H. [1 ]
Murata K. [2 ]
Mukai M. [3 ]
Akedo H. [3 ]
机构
[1] Tumor Biochemistry, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka
关键词
Apigenin; Azoxymethane; Bombesin; Cancer metastasis; Intestinal cancer; MAPK; MMP-9;
D O I
10.1023/A:1013133803806
中图分类号
学科分类号
摘要
The effect of a naturally occurring flavonoid apigenin on the development of bombesin-enhanced peritoneal metastasis from intestinal adenocarcinomas induced by azoxymethane was investigated in male Wistar rats. From the start of the experiment, rats were given weekly s.c. injections of azoxymethane (7.4 mg/kg body weight) for 10 weeks and s.c. injection of bombesin (40 μg/kg body weight) every other day, and from week 16, s.c. injections of apigenin (0.75 or 1.5 mg/kg body weight) every other day until the end of the experiment in week 45. Bombesin significantly increased the incidence of intestinal tumors and cancer metastasis to the peritoneum in week 45. It also significantly increased the labeling index of intestinal cancers. Although administration of apigenin at either dose with bombesin had little or no effect on the enhancement of intestinal carcinogenesis by bombesin, the location, histologic type, depth of involvement, infiltrating growth patterns and labeling index, it was found to decrease significantly the incidence of cancer metastasis. Apigenin significantly decreased the incidence of lymphatic vessel invasion of adenocarcinomas, which was enhanced by bombesin. In vitro experiments revealed that apigenin inhibited bombesin-enhanced phosphorylation of mitogen-activated protein kinase (MAPK), but not matrix metalloprotease (MMP)-9 expression. Our findings indicate that apigenin inhibits cancer metastasis through inhibition of phosphorylation of MAPK.
引用
收藏
页码:657 / 662
页数:5
相关论文
共 21 条
  • [1] Iishi H., Tatsuta M., Baba M., Et al., Genistein attenuates peritoneal metastasis of azoxymethane-induced intestinal adenocarcinomas in Wistar rats, Int J Cancer, 86, pp. 416-420, (2000)
  • [2] Fotsis T., Pepper M.S., Aktas E., Et al., Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis, Cancer Res, 57, pp. 2916-2921, (1997)
  • [3] Fotsis T., Pepper M.S., Montesano R., Et al., Phytaestrogens and inhibition of angiogenesis, Baillieres Clin Endocrinol Metab, 12, pp. 649-666, (1998)
  • [4] Iishi H., Tutsuta M., Baba M., Et al., Enhancement by bombesin of colon carcinogenesis and metastasis induced by azoxymethane in Wistar rats, Int J Cancer, 50, pp. 834-839, (1992)
  • [5] Iishi H., Tatsuta M., Baba M., Et al., Ornithine decarboxylase inhibitor attenuates bombesin enhancement of intestinal carcinogenesis and metastasis induced by azoxymethane, Int J Cancer, 58, pp. 533-537, (1994)
  • [6] General Rules for Clinical and Pathological Studies on Cancer of the Colon. Rectum and Anus, 6th ed., (1998)
  • [7] Liao G., Zhang Y., Shen M., Et al., Significance of proliferating cell nuclear antigen expression in liver metastasis of colorectal cancer, Dis Colon Rectum, 40, pp. 1489-1493, (1997)
  • [8] Reddy K.B., Krueger J.S., Kondapaka S.B., Et al., Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-6) in breast epithelial cells, Int J Cancer, 82, pp. 268-273, (1997)
  • [9] Siegel S., Nonparametric Statistics for the Behavioral Sciences, (1956)
  • [10] Miller Jr. R.G., Simultaneous Statistical Inference, (1966)